MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Quick Stats
Jan 30, 202655.5
AI Score
HOLD1.15
Volume Ratio
Feb 25, 2026
Next Earnings
8
+ve Days (30d)
22
-ve Days (30d)
MDXG Stock Summary
Last updated Jan 30, 2026
MDXG is currently trading at $5.11, positioned below its 200-day moving average of $6.74, suggesting bearish momentum. The stock has a 52-week range of $5.05 to $9.15.
Technical Analysis: The 50-day moving average stands at $6.43, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 22.066, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.234, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MDXG at 55.5/100 with a HOLD recommendation.
MDXG (MiMedx Group, Inc) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 22.066 |
| CMF (20) | -0.234 |
| ROC (10) | -11.13 |
| ADX (14) | 47.69 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.425 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -94.643 |
| MFI (14) | 29.81 |
MDXG Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MDXG Price vs Max Options Open Interest
MDXG Max Change In Options Open Interest
MDXG Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MDXG Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MDXG Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MDXG Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MiMedx Group, Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MDXG Moving Averages Analysis
MDXG (MiMedx Group, Inc) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 5.28 |
| 20 | 5.71 |
| 30 | 6.13 |
| 50 | 6.43 |
| 100 | 6.75 |
| 200 | 6.74 |
MDXG Fundamental Analysis
| P/E (Forward) | 19.5313 |
| P/E (Trailing) | 19.0741 |
| Market Cap ($) | 762.7 million |
| Earnings/Share ($) | 0.27 |
| Net Proft Margin (%) | 0.1038 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.42 |
| EPS Estimate Next Year ($) | 0.12 |
| WallStreet Target Price ($) | 10.4 |
| Most Recent Quarter |